Growth & profitability
- Revenue has declined 2.7% per year over the past 5 years.
- Operating margin has expanded, at -60.5% in the latest year.
Financial health
- Total debt has grown slower than revenue (-48.3% vs -2.7% per year).
CRIS Financials CURIS INC
15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $9M | -$8M | 0.0% | -60.5% | — | — | $5M |
| 2024 | $11M | -$43M | 0.0% | -408.3% | — | — | $20M |
| 2023 | $10M | -$47M | 0.0% | -482.2% | -$38M | — | $27M |
| 2022 | $10M | -$57M | 0.0% | -521.7% | -$55M | — | $20M |
| 2021 | $11M | -$45M | 0.0% | -395.0% | -$38M | — | $40M |
| 2020 | $11M | -$30M | 0.0% | -229.8% | -$26M | $891000 | $130M |
| 2019 | $10M | -$32M | 0.0% | -243.5% | -$26M | $0 | $15M |
| 2018 | $10M | -$33M | 0.0% | -281.3% | -$30M | $35M | $24M |
| 2017 | $10M | -$53M | 0.0% | -502.7% | -$49M | $42M | $38M |
| 2016 | — | -$60M | — | — | -$36M | $20M | $26M |
| 2015 | — | -$59M | — | — | -$30M | $24M | $33M |
| 2014 | — | -$19M | — | — | -$17M | $28M | $8M |
| 2013 | — | -$12M | — | — | -$10M | $31M | $10M |
| 2012 | — | -$16M | — | — | -$15M | $30M | $13M |
| 2011 | — | -$10M | — | — | -$5M | — | $15M |
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $0 | -$24M | — | — | — | — | $15M |
| Dec '25 | $1M | $19M | 0.0% | 1724.0% | — | — | $5M |
| Sep '25 | $3M | -$8M | 0.0% | -218.0% | — | — | $9M |
| Jun '25 | $3M | -$9M | 0.0% | -300.1% | — | — | $10M |
| Mar '25 | $2M | -$11M | 0.0% | -426.8% | — | — | $20M |
| Dec '24 | $3M | -$10M | 0.0% | -268.9% | — | — | $20M |
| Sep '24 | $3M | -$10M | 0.0% | -360.5% | — | — | $21M |
| Jun '24 | $3M | -$12M | 0.0% | -491.4% | — | — | $10M |
| Mar '24 | $2M | -$12M | 0.0% | -597.7% | — | — | $30M |
| Dec '23 | $3M | -$12M | 0.0% | -452.5% | -$10M | — | $27M |
| Sep '23 | $3M | -$12M | 0.0% | -436.6% | -$8M | — | $24M |
| Jun '23 | $2M | -$12M | 0.0% | -552.5% | -$8M | — | $20M |
| Mar '23 | $2M | -$12M | 0.0% | -506.2% | -$12M | — | $32M |
| Dec '22 | $3M | -$11M | 0.0% | -354.0% | -$12M | — | $20M |
| Sep '22 | $3M | -$13M | 0.0% | -446.2% | -$13M | — | $30M |
| Jun '22 | $2M | -$16M | 0.0% | -629.4% | -$12M | — | $34M |
| Mar '22 | $2M | -$16M | 0.0% | -735.7% | -$17M | — | $18M |
| Dec '21 | $3M | -$14M | 0.0% | -400.9% | -$8M | — | $40M |
| Sep '21 | $3M | -$11M | 0.0% | -330.6% | -$10M | $0 | $53M |
| Jun '21 | $2M | -$11M | 0.0% | -465.9% | -$7M | $0 | $75M |
Valuation over time
How the market has priced CRIS against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-sales ratio has fallen from 2.3× (Mar '23) to 0.8× (Jun '26).
P/S
Frequently asked questions
Is CRIS growing its revenue and profit?
Over the past 5 years, CURIS INC's revenue has declined 2.7% per year. These are computed facts, not advice.
How much debt does CRIS have?
As of FY2025, CURIS INC reported — of total debt against $5M of cash.
What is CRIS's profit margin?
In FY2025, gross margin was —, operating margin -60.5%, and net margin -80.3%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.